Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
7 Results for "
USP39
" in MedChemExpress (MCE) Product Catalog:
Products (7)
7 Results for "USP39" in MCE Product Catalog:
Cat. No.: HY-180907
Target:
Research Areas:
PROTAC USP39 Degrader-1 is a USP39 PROTAC degrader with Kd values of 136 nM and 232 nM, and a DC50 value of 1.06 nM (24 h). PROTAC USP39 Degrader-1 binds to the VHL E3 ubiquitin ligase, forms a ternary complex with USP39, mediates USP39 ubiquitination and proteasomal degradation dependent on VHL recruitment, modulates splicing activity and induces 5' splice site-specific splicing patterns. PROTAC USP39 Degrader-1 can be used in the research of cervical cancer .
Cat. No.: HY-RS15550
Target:
Research Areas:
USP39 Human Pre-designed siRNA Set A contains three designed siRNAs for USP39 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS19044
Target:
Research Areas:
Usp39 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Usp39 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25534
Target:
Research Areas:
Usp39 Rat Pre-designed siRNA Set A contains three designed siRNAs for Usp39 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-180906
CAS No.: 2243090-28-8
Research Areas:
(S,R,S)-AHPC-C2-PEG3-NH2 is an E3 ligase ligand-linker conjugate, can be used for synthesis of PROTAC USP39 Degrader-1 (HY-180907) .
Cat. No.: HY-P87133
Synonyms: 65K antibody; CGI 21 antibody; CGI-21 antibody; FLJ33136 antibody; HSPC332 antibody; Inactive ubiquitin specific peptidase 39 antibody; Inactive ubiquitin-specific peptidase 39 antibody; MGC75069 antibody; PRO2855 antibody; S. CEREVISIAE, HOMOLOG OF SAD1 antibody; 65K antibody; CGI 21 antibody; CGI-21 antibody; FLJ33136 antibody; HSPC332 antibody; Inactive ubiquitin specific peptidase 39 antibody; Inactive ubiquitin-specific peptidase 39 antibody; MGC75069 antibody; PRO2855 antibody; S. CEREVISIAE, HOMOLOG OF SAD1 antibody; SAD1 antibody; SAD1 homolog antibody; Small nuclear ribonucleoprotein 65kDa (U4/U6.U5) antibody; snRNP ASSEMBLY DEFECTIVE 1 antibody; SnRNP assembly defective 1 homolog antibody; SNRNP65 antibody; SNUT2_HUMAN antibody; U4/U6.U5 tri snRNP associated 65 kDa protein antibody; U4/U6.U5 tri snRNP associated protein 2 antibody; U4/U6.U5 tri-snRNP-associated 65 kDa protein antibody; U4/U6.U5 tri-snRNP-associated protein 2 antibody; Ubiquitin specific peptidase 39 antibody; Ubiquitin specific protease 39 antibody; USP39 antibody;
Cat. No.: HY-P87134
Synonyms: 65K antibody; CGI 21 antibody; CGI-21 antibody; FLJ33136 antibody; HSPC332 antibody; Inactive ubiquitin specific peptidase 39 antibody; Inactive ubiquitin-specific peptidase 39 antibody; MGC75069 antibody; PRO2855 antibody; S. CEREVISIAE, HOMOLOG OF SAD1 antibody; 65K antibody; CGI 21 antibody; CGI-21 antibody; FLJ33136 antibody; HSPC332 antibody; Inactive ubiquitin specific peptidase 39 antibody; Inactive ubiquitin-specific peptidase 39 antibody; MGC75069 antibody; PRO2855 antibody; S. CEREVISIAE, HOMOLOG OF SAD1 antibody; SAD1 antibody; SAD1 homolog antibody; Small nuclear ribonucleoprotein 65kDa (U4/U6.U5) antibody; snRNP ASSEMBLY DEFECTIVE 1 antibody; SnRNP assembly defective 1 homolog antibody; SNRNP65 antibody; SNUT2_HUMAN antibody; U4/U6.U5 tri snRNP associated 65 kDa protein antibody; U4/U6.U5 tri snRNP associated protein 2 antibody; U4/U6.U5 tri-snRNP-associated 65 kDa protein antibody; U4/U6.U5 tri-snRNP-associated protein 2 antibody; Ubiquitin specific peptidase 39 antibody; Ubiquitin specific protease 39 antibody; USP39 antibody;
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
